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Abstract
Bisphenol-A (BPA) is a widespread endocrine-disrupting chemical (EDC) used as the base compound in the manufacture of
polycarbonate plastics. It alters pancreatic b-cell function and can be considered a risk factor for type 2 diabetes in rodents.
Here we used ERb2/2 mice to study whether ERb is involved in the rapid regulation of KATP channel activity, calcium
signals and insulin release elicited by environmentally relevant doses of BPA (1 nM). We also investigated these effects of
BPA in b-cells and whole islets of Langerhans from humans. 1 nM BPA rapidly decreased KATP channel activity, increased
glucose-induced [Ca2+]i signals and insulin release in b-cells from WT mice but not in cells from ERb2/2 mice. The rapid
reduction in the KATP channel activity and the insulinotropic effect was seen in human cells and islets. BPA actions were
stronger in human islets compared to mouse islets when the same BPA concentration was used. Our findings suggest that
BPA behaves as a strong estrogen via nuclear ERb and indicate that results obtained with BPA in mouse b-cells may be
extrapolated to humans. This supports that BPA should be considered as a risk factor for metabolic disorders in humans.
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Introduction
Bisphenol-A (BPA) is a widespread endocrine disruptor that
produces insulin resistance and alterations in pancreatic b-cell
function [1]. It has been suggested that together with other
endocrine disrupting chemicals (EDCs), BPA constitutes a risk
factor for type 2 diabetes and other metabolic disorders [2–4].
Recent work shows the association between increasing urinary
BPA levels and Diabetes Mellitus. A 12.8% of diabetic patients
show high BPA levels in urine samples (4.20 ng/ml or 18 nM) [5].
Moreover an association between urinary levels of BPA, obesity
and insulin resistance in middle-aged and elderly chinese adults
has been recently described [6]. The range of BPA levels found in
humans is from 0.7 to 20 nM [7,8]. To support the evidence that
BPA may be a risk for the development of diabetes it is critical to
study its effect on human tissues involved in glucose and lipid
metabolism, including the endocrine pancreas which is key in
glucose homeostasis.
The islet of Langerhans is the physiological unit of the
endocrine pancreas; it is a group of 1500–3000 cells of five
different types [9–11], and the most abundant are b-cells. The
main function of b-cells is the biosynthesis and release of insulin in
response to neurotransmitters, hormones and nutrients, the most
important being glucose. The secretory response of b-cells depends
on their electrical activity. This consists of oscillations of the
membrane potential that range from electrically silent periods to
depolarized plateaus on which Ca2+-action potential originate
[12]. Classically, stimulus-secretion coupling involves the closure
of KATP channels after an increase in the ATP/ADP ratio because
of the glucose metabolism [13]. KATP channels are responsible for
the resting membrane potential of b-cells and its closure elicits a
depolarization that opens voltage dependent calcium channels and
induces Ca2+ influx [14]. As a consequence of the oscillatory
membrane potential, a [Ca2+]i oscillatory pattern originates [15–
19], which triggers a pulsatile insulin secretion [17–19]. In
addition to the KATP dependent process of insulin secretion there
is a KATP independent process which involves cAMP dependent
phosphorylation [20,21].
Beta cells express estrogen receptor a (ERa), estrogen receptor b
(ERb) and the G-protein coupled receptor (GPR30), also named
GPER1 [22,23]. The use of genetically modified mice has revealed
the role of these estrogen receptors [23]. ERa is involved in the
regulation of pancreatic insulin biosynthesis in response to both E2
and BPA. Remarkably, nanomolar concentrations of either BPA
or E2 act via extranuclear ERa to activate ERK1/2 and regulate
insulin content [24]. This action involves the activation of the
transcription factor NeuroD1 [25]. In addition, activation of
extranuclear ERb by physiological concentrations of E2 rapidly
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regulates KATP channel activity, increases glucose stimulated
[Ca2+]i signals and insulin release. It is important to clarify that
action of E2 on KATP channel activity was mimicked by specific
agonist of ERb 2,3-bis (4-hydroxyphenyl)-propionitrile (DPN) but
not by the ERa specific agonist propylpyrazole-triol (PPT).
Moreover KATP channel activity was not modified in ERa2/2
[26]. These results indicated that ERb plays an important role in
rapid regulation of insulin secretion in pancreatic b-cells. Bi-
sphenol-A imitated rapid estradiol regulation of KATP channel and
calcium signaling [1], however, whether ERb acting out of the
nucleus is able to mediate BPA actions is still unknown.
In the present work we use b-cells and islets of Langerhans from
wild type (WT) and ERb2/2 mice to show that ERb is involved
in the BPA-mediated rapid regulation of KATP channel activity,
potentiation of glucose induced-[Ca2+]i signals and insulin release.
Moreover, we have used human islets of Langerhans to
demonstrate that 1 nM BPA blocked KATP channels and
produced a potent enhancement of insulin secretion in response
to glucose.
Materials and Methods
Animals
Adult C57 female mice were used. All animals were kept under
standard housing conditions. The ethical committee of Miguel
Hernandez University ‘‘Comisio´n de E´tica en la Investigacio´n
Experimental’’ reviewed and approved the method used. ERb2/2
mice were generated as described prior [27] and supplied by Jan-
Ake Gustafsson’s laboratory. All genetically modified animals and
wild types were from the same supplier and the same colony. Islets
of Langerhans from ERb2/2 mice were treated as described
below for islets from C57 mice. Animals were kept in new
polycarbonate cages and polycarbonate water bottles were avoided
to minimize contamination of mice with free BPA.
Islet of Langerhans isolation from mice
Adult mice were killed by cervical dislocation and islets were
isolated with a collagenase technique previously described [26]
and used according to the kind of experiment to be performed.
Human islets isolation for electrophysiological
experiments
Human pancreases were obtained from 3 cadaveric organ
donors, after written consent of their families and approval of
‘‘Comite´ E´tico de Investigacio´n Clı´nica’’, and ‘‘Comite´ de
Investigacio´n’’, Hospital Clı´nic of Barcelona (ID: 2009/5157).
Islets were isolated by collagenase digestion of the pancreas
(SERVA Electrophoresis, Heidelberg, Germany) and separated
from exocrine tissue by Biocoll density gradient (Biochrom,
Berlin,Germany), as previously described [28]. Islets were
transferred to RPMI-1640 medium (Gibco-BRL, Pisley, U.K.)
containing 11.1 mmol/l glucose and supplemented with 10%
FBS, 2 mmol/l L-glutamine, 100 units/ml penicillin, and 100 mg/
ml streptomycin and cultured overnight at 37uC with 5% CO2.
Islets were then picked and disaggregated to obtain beta cells for
electrophysiological studies as described below.
Obtaining b-cells from mouse and human islets
Once mouse or human islets were obtained as described above,
they were dispersed into single cells and cultured as previously
described [14]. The protocol of islet disaggregation into sinlge cells
was the same for both mouse and human islets. Once isolated,
islets were disaggregated into single cells in a low calcium medium.
Cells were then centrifuged, resuspended in culture medium
RPMI 1640 without phenol red containing 11 mM glucose
supplemented with 10% charcoal dextran-treated fetal bovine
serum (HyClone Laboratories, Logan, UT), 2 mM L-glutamine,
200 U/mL penicillin and 0.2 mg/mL streptomycin and plated on
glass coverslips. Cells were kept at 37uC, in a humidified
atmosphere of 95% O2 and 5% CO2, and used within 1–2 days
of culture.
Insulin secretion measurements in mouse islets
Freshly isolated islets of Langerhans from mice were left to
recover in the isolation medium for 2 h in the incubator. After
recovery, groups of 5 were transferred to 400 ml of a buffer
solution containing 140 mM NaCl, 4.5 mM KCl, 2.5 mM CaCl2,
1 mM MgCl2, 20 mM HEPES and the glucose concentration
corresponding to each experimental condition with final pH at 7.4.
Afterwards, 100 ml of the corresponding buffer solution with 5%
Bovine Serum Albumin (BSA) was added, incubated at room
temperature for 3 min and let to cool down for 15 min on ice.
Then, the medium was collected and insulin was measured in
duplicate samples by radioimmunoassay using a Coat-a-Count kit
(Siemens, Los Angeles, CA, USA).
Recording intracellular calcium concentration ([Ca2+]i)
Freshly isolated islets of Langerhans from mice were loaded with
5 mM Fura-2 AM for at least 1 h at room temperature. Calcium
recordings in islets were obtained by imaging intracellular calcium
under an inverted epifluorescence microscope (Zeiss, Axiovert
200). Images were acquired every 2 s with an extended
Hamamatsu Digital Camera C4742-95 (Hamamatsu Photonics,
Barcelona, Spain) using a dual filter wheel (Sutter Instrument CO,
CA, USA) equipped with 340 nm and 380 nm, 10 nm bandpass
filters (Omega optics, Madrid, Spain). Data were acquired using
Aquacosmos software from Hamamatsu (Hamamatsu Photonics,
Barcelona, Spain). Results were plotted and analyzed using
commercially available software (Sigmaplot, Jandel Scientific).
Data were represented as a frequency of calcium oscillations
(min21) comparing BPA responses with their respective control.
Patch Clamp recordings
KATP channel activity was recorded using standard patch clamp
recording procedures from isolated b-cells [29]. 80–90% of the
single cells were identified as b-cells by their large size
(capacitance: 8–12 pF) and by their electrophysiological proper-
ties, such as presence of KATP channel activity in absence of
glucose and their response to glucose by the appearance of action
currents in cell-attached configuration. Currents were recorded
using an Axopatch 200B patch-clamp amplifier (Axon Instruments
Co. CA, USA). Patch pipettes were pulled from borosilicate
capillaries (Sutter Instruments Co. CA, USA) using a flaming/
brown micropipette puller P-97 (Sutter Instruments Co. CA, USA)
with resistance between 3–5 MV when filled with the pipette
solutions as specified below. Bath solution contained (in mM): 5
KCl, 135 NaCl, 2.5 CaCl2, 10 Hepes and 1.1 MgCl2 (pH 7.4) and
supplemented with glucose as indicated. The pipette solution
contained (in mM): 140 KCl, 1 MgCl2, 10 Hepes and 1 EGTA
(pH 7.2). The pipette potential was held at 0 mV throughout
recording. KATP channel activity was quantified by digitising 60 s
sections of the current record, filtered at 1 kHz, sampled at
10 kHz by a Digidata 1322A (Axon Instruments Co. CA, USA),
and calculating the mean open probability of the channel (NP o)
during the sweep. Channel activity was defined as the product of
N, the number of functional channels, and Po, the open-state
probability. Po was determined by dividing the total time channels
spent in the open state by the total sample time. Data were
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represented as a percentage of activity with respect to resting
conditions (0 mM Glucose). Experiments were carried out at room
temperature (20–24uC).
Human pancreatic islets and measurement of human
islet insulin secretion
Isolated human pancreatic islets from non-diabetic males (age
58+6 years; Hb1Ac,6.1 and MBI: 27+2) were provided by the
Nordic network for clinical islet transplantation (Professor Olle
Korsgren, Uppsala University, Sweden). All procedures were
approved by the ethical committees at Uppsala and Lund
Universities. Prior to the experiments the islets had been cultured
at 37uC (5% CO2) for 2 days in CMRL 1066 (ICN Biomedicals,
Costa Mesa, CA) supplemented with 10 mmol/l HEPES,
2 mmol/l L-glutamine, 50 mg/ml gentamicin, 0.25 mg/ml Fungi-
zone (Gibco, BRL, Gaithersburg, MD), 20 mg/ml ciprofloxacin
(Bayer Healthcare, Leverkusen, Germany) and 10 mmol/l nico-
tinamide. The islets had 70–90% purity when they arrived; the
islets were then hand-picked under stereomicroscope prior to use.
All islet preparations were treated in exactly the same way to avoid
results being due to handling differences. All procedures were
approved by the ethical committees at Uppsala and Lund
Universities.
At the experiment day, the islets were preincubated for 30 min
at 37uC in Krebs-Ringer bicarbonate buffer, pH 7.4, supplement-
ed with 10 mmol/l HEPES, 0.1% bovine serum albumin and
1.0 mmol/l glucose. After preincubation the buffer was changed
and the islets were incubated at 8.3 mmol/l glucose 6 different
test agents for 60 min at 37uC. Each incubation tube contained 12
islets in 1.0 ml of KRB solution and was gassed with 95% O2 5%
CO2 to obtain constant pH and oxygenation. All incubations were
performed in an incubation box at 30 cycles/min. immediately
after incubation an aliquot of the medium was removed and frozen
for subsequent assay of insulin. The secreted insulin was measured
using a radioimmunoassay kit (Millipore).
Results
BPA action on KATP channel activity is abolished in b-cells
from ERb2/2 mice
Bisphenol-A application in presence of 8 mM glucose during
1 hour increased insulin release from mouse islet of Langerhans in
a dose dependent manner (Figure 1A). For the rest of the work we
used 1 nM BPA because is within the range of BPA levels in
human serum and it is considered an environmentally relevant
dose [7,8].
Figure 2A shows, in a typical b-cell from wt mice, the basal
activity of KATP channels (upper trace). Channel openings are
represented by downward deflections, reflecting inward currents
due to the high potassium content of the pipette. The criterion
used for identification of KATP channels was their sensitivity to
glucose, which highly decreases channel activity (Fig. 2A, 8 mM
glucose trace) and diazoxide, a sulfonamide that opens KATP
channels (Fig. 2A, 100 uM diazoxide trace). Both glucose and
diazoxide sensitivity were tested in all records throughout this
work. Figure 2A (BPA trace) demonstrates the decrease in the
KATP channel activity elicited by BPA, 7 min after its application.
On average, BPA decreases KATP channel activity by 49.3%
(Fig. 2B).
To molecularly study the role of ERb in BPA-induced rapid
regulation of KATP channels, cell-attached patch recordings were
performed in b-cells from ERb2/2 mice. In these cells KATP
channel activity was not significantly altered after BPA application
(Fig. 2C and D).
BPA closes KATP channels in human b-cells
In order to analyze whether the rapid action of BPA on KATP
channel activity occurred as well in human pancreatic b-cells, islets
from human donors were disaggregated into single cells and single
channel recordings were performed using the patch-clamp
technique as performed in the previous subheading. Figure 3A
shows a typical record in which 5 min after BPA application in the
absence of glucose, there is a dramatic decrease in KATP channel
activity by 83.4%, together with a depolarization of the membrane
noticed by the decrease in the amplitude of the channel opening
and the appearance of biphasic spikes (see * and ** in second and
third traces and figure 3B). These biphasic spikes (action currents)
were seen in all human cells exposed to either BPA or glucose and
are action potentials seen via the capacitance and resistance of the
patch and their recordings depend on the patch resistance [14,30].
Remarkably, the response to BPA in the average of experiments is
as high as that of 8 mM glucose (Fig. 3C). The action of BPA was
mimicked by the ERb agonist diaylpropionitrile (DPN) (Figure
S1).
BPA action on glucose induced [Ca2+]i oscillations and
insulin release is abolished in islets from ERb2/2 mice
It is well established that E2 rapidly induces Ca2+ signals and
insulin secretion via ERb in a process that depends on electrical
activity [26]. To investigate whether activation of ERb by BPA
potentiated glucose-induced [Ca2+]i signals and insulin secretion,
we performed the experiments described in Figures 4 and 5. Islets
loaded with the calcium fluorescence dye Fura-2 were imaged to
monitor the [Ca2+]i signal elicited by a change from a non
stimulatory glucose concentration (3 mM) to an insulin stimulatory
glucose concentration (8 mM). The response, as expected, was a
[Ca2+]i transient followed by a plateau with [Ca
2+]i oscillations. In
the absence of BPA the frequency of [Ca2+]i oscillations was
similar in islets isolated from wt and ERb2/2 mice (Fig. 4A and
C). However the frequency of [Ca2+]i oscillations increased in islets
exposed to 1 nM BPA compared to control in wt islets (Fig. 4B
and C). It is of note that the BPA-induced increase in [Ca2+]i
oscillatory frequency is highly diminished in islets from ERb2/2
Figure 1. BPA increases insulin release in a dose dependent
manner in mouse islet of langerhans. The released insulin was
measured after one hour exposure of islets to increasing concentration
of BPA, in the presence of 8 mM glucose. All points contained same
amount of vehicle.
doi:10.1371/journal.pone.0031109.g001
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animals (Figure 4C). This experiment indicates that ERb is
involved in the BPA potentiation of glucose induced oscillatory
activity.
In addition, BPA enhanced insulin release stimulated by 8 mM
glucose islets from wt animals (Fig. 5A) but it had no effect in islets
from ERb2/2 mice (Fig. 5B). Note that BPA had an effect only
when a stimulatory glucose concentration (8 mM) was used; when
BPA was applied together with 3 mM glucose no effect was
observed.
Insulinotropic action of BPA on human islets of
Langerhans
The rapid effect of 1 nM BPA on glucose stimulated insulin
release was studied on human islets from two different donors.
Islets responded to 8 mM glucose with an increase of insulin
secretion. The action of 8 mM glucose was enhanced almost 2 fold
by the presence of 1 nM BPA (Fig. 6). The ERb agonist DPN
applied at 1 nM concentration also enhanced insulin secretion, but
to a lesser extent than 1 nM BPA (Fig. 6). This experiment
indicates that environmentally relevant doses of BPA have an
insulinotropic action on human islets of Langerhans.
Discussion
The findings of this work using b-cells and whole islets of
Langerhans from human donors demonstrate that the widespread
endocrine disruptor BPA induces a rapid decrease of the activity of
KATP channels, a key molecule in the stimulus secretion coupling
of b-cells. Moreover, the present work demonstrates that
environmentally relevant doses of BPA (1 nM) stimulated
glucose-induced insulin secretion in human islets, giving a response
which is almost twice the insulin release elicited by a stimulatory
glucose concentration, 8 mM. These results together with previous
observations that BPA diminished adiponectin release in human
adipocytes [31,32] support the premise that BPA has adverse
effects on glucose metabolism in adult humans. Additionally,
epidemiological evidence links BPA levels in urine with metabolic
disorders in adult humans. These include type-2 diabetes,
cardiovascular diseases and insulin resistance [33,34].
In adult rodents, BPA exposure at environmentally relevant
doses provokes insulin resistance and hyperinsulinemia in the fed
state [35]. The hyperinsulinemia is not just a consequence of
insulin resistance, because BPA directly regulates pancreatic
insulin content and insulin release in isolated islet of Langerhans
Figure 2. KATP channel activity in pancreatic b-cells fromWT and ERb2/2mice in presence of 1 nM BPA. A, BPA at 1 nM decreased KATP
channel activity in pancreatic b-cells from WT mice. The records show channel activity before application of BPA (upper trace), 7 min after application
of BPA (1 nM BPA trace), 8 min after application of 8 mM Glucose (8 mM glucose trace) and 2 min after application of diazoxide (100 mM diazoxide
trace) (n = 7). B, percentage of activity of the KATP channels elicited by vehicle and 1 nM BPA. C, 1 nM BPA had no significant effect on KATP channel
activity in pancreatic ERb2/2 mice. As in A, the records show KATP channel activity before application of BPA, 7 min after application of 1 nM BPA,
8 min after application of 8 mM glucose and 3 min after application of 100 mM diazoxide (n = 5 cells for 3 different mice). D, percentage of activity of
KATP channels elicited by vehicle and 1 nM BPA. *, P,0.05 Student’s test comparing 1 nM BPA with control.
doi:10.1371/journal.pone.0031109.g002
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from the mouse [24]. Remarkably, this action occurred at low
concentrations of BPA (1 nM) via activation of extranuclear ERa
in a nonclassical manner that involves ERK1/2 activation and a
nonmonotonic dose response [24]. The rapid effect described in
the present work using b-cells from ERb2/2 mice demonstrates
that ERb is involved in the inhibition of KATP channel activity and
in the regulation of glucose-induced [Ca2+]i signals and insulin
release. These actions imitate those of the natural hormone E2,
and BPA and E2 are equally potent at 1 nM. It must be noted,
however, that experiments performed in figures 2 and 4 using cells
from ERb2/2 mice show a trend toward reduction in KATP
channel activity and increased calcium signaling. In addition to
ERa and ERb, other non-classical membrane estrogen receptors
(ncmER) involved in rapid BPA action have been described in b
and a-cells [1,23,36]. GPR30 may be one of this ncmER because
it exists in b-cells and is involved in cell survival [22,37] and in
glucose stimulated insulin secretion in response to supraphysio-
logical concentrations of 17b-estradiol [22,38]. Moreover,
ncmERs may play a role in the supression of adiponectin release
by BPA in mouse and human adipocytes [32].
BPA has been considered a weak estrogen because of its low
binding affinity to both ERa and ERb [39], as well as a low
transcriptional activity through these ERE binding receptors [40].
ERa and ERb control nuclear processes that include proliferation,
apoptosis and migration exerting opposite effects in different
tissues [41]. Nevertheless, it is fully accepted today that estrogen
receptors do not work only in this classical manner but they signal
as wellfrom extranuclear locations to exert a plethora of actions in
different types of cells [37,42–45]. In b-cells non-classical estrogen
triggered pathways include regulation of insulin biosynthesis by
ERa [24,25], regulation of glucose stimulated insulin release by
ERb [26], improvement of cell survival by ERa and to a lesser
extent by ERb and GPR30 [37] and control of lipid synthesis by
extranuclear ERa [45]. The nonclassical actions of estrogen
receptors have main implications in energy balance as demon-
strated using genetic rescue of nonclassical ER signalling in ER2/2
mice [46]. The use of ERb2/2 mice in the present work and
ERa2/2mice in a previous work [24] unequivocally demonstrates
that both receptors acting though nonclassical pathways mediate
BPA and E2 actions at equal concentrations (Fig. 7). Therefore,
BPA cannot be considered a weak estrogen anymore, at least not in
b-cells. Nevertheless, why the BPA effects occur at low doses when
ERs are located in the extranuclear compartment is a matter of
future research. It is possible that BPA binds differently to ERa and
ERb when they are located outside the nucleus. Also the
recruitment of co-activators or co-repressors may be completely
different [47]. Some of these effects may even be cell-specific. For
instance, the insulinotropic action of BPA shown in this work occurs
in the presence of a stimulatory glucose concentration of 8 mM.
Under this condition most KATP channels are already closed and
therefore the membrane resistance is high, so that a small current
will elicit the depolarization of the membrane, electrical activity,
Ca2+ signals and insulin release. This occurs in b-cells because KATP
channels control the resting membrane potential and determine the
electrical resistance of the cell [48]. This implies that the closure of a
small number of KATP channels by BPA will produce an
insulinotropic action.
In the case of human islets, BPA had a similar action to that in
mice. It elicited a decrease in the KATP channel activity which was
stronger than that in mice when the same dose of BPA was used.
Moreover, its insulinotropic action was much stronger in human
cells that in mice at the same dose. These results clearly
demonstrate that environmentally relevant doses of BPA (1 nM)
have an insulinotropic action on human islets. It is of note that the
concentrations of BPA found in humans range from 0.7 to 20 nM
[7,8] and therefore the effect demonstrated here with islets from
human donors may occur in vivo at usual levels of exposure. Rapid
release of insulin in vivo in response to 10 mg/kg BPA was already
Figure 3. BPA regulation of KATP channel activity in human pancreatic b-cells. A, Application of 1 nM BPA decreased KATP channel activity in
isolated human pancreatic b-cells in absence of glucose. The records show KATP channel activity in absence of glucose (vehicle trace), 5 min after
application of 1 nM BPA, 8 min after application of 8 mM glucose and 3 min after application of 100 mM diazoxide. B, Both 8 mM glucose and 1 nM
BPA depolarized membrane potential and action currents were generated (see * and ** in second and third traces in figure 2A). C, Percentage of
activity of KATP channel elicited by vehicle, 1 nM BPA and 8 mM glucose in single b-cells (n = 5 cells). **, P,0.01 Student’s test comparing 1 nM BPA
and 8 mM glucose with control.
doi:10.1371/journal.pone.0031109.g003
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Figure 4. Effect of 1 nM BPA on glucose induced [Ca2+]i oscillations in pancreatic b-cells from WT and ERb2/2mice. A, Application of
8 mM glucose elicited a [Ca2+]i transient followed by a plateau with [Ca
2+]i oscillations in pancreatic b-cells from both WT and ERb2/2 mice. B,
application of 8 mM glucose in the presence of 1 nM BPA enhanced [Ca2+]i oscillations frequency in WT islets but not in ERb2/2 islets. Recordings
are representatives of at least 8 different islets from at least 4 different mice. C, frequency of [Ca2+]i oscillations in pancreatic islets fromWT and ERb2/2
mice in the absence of BPA (black bar) and in the presence of 1 nM BPA (white bar). Each point is the mean of at least eight different experiments. The
analysis of the frequency was done during 5 min period, always taken when a steady state was reached, usually 8–10 min after 8 mM glucose
application. *, P,0.05 Student’s test.
doi:10.1371/journal.pone.0031109.g004
Figure 5. BPA effect on glucose-induced insulin secretion from isolated islets from WT and ERb2/2 mice. A, 1 nM BPA induced insulin
secretion from WT islets exposed to 3 mM glucose and 8 mM glucose for 1 h. Note that 1 nM BPA action was significant only when 8 mM glucose
was used. B, Same experiment as performed in A, but using ERb2/2 islets. Note that 1 nM BPA effect was abolished at 8 mM glucose (n = 5).
*, P,0.05 Student’s t-test comparing 8 mM glucose with 8 mM glucose in presence of 1 nM BPA.
doi:10.1371/journal.pone.0031109.g005
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reported in mice [35]. An excessive insulin signalling produced by
an overstimulation of b-cells by BPA exposure may produce
dyslipidemia resulting from effects in the liver and adipose tissue,
and obesity and glucose intolerance [49]. In addition it may
provoke insulin resistance in liver and skeletal muscle together with
b-cell exhaustion, contributing to the development of type-2
diabetes [1]. Alterations of glucose and lipid metabolism by BPA
in adults may constitute a significant hazard during pregnancy for
both mothers and offspring as demonstrated in mice and rats
[50,51].
The ERb agonist DPN also closed KATP channels and rapidly
induced insulin release in human b-cells but to a smaller extent
compared to mice. Given the scarcity of human islets we do not
have enough data to definitely conclude that ERb is the main
receptor involved. The fact that ERb mediates the insulinotropic
action of BPA in mice does not rule out the possibility that other
receptors such as GPR30/GPER1, which also bind BPA, may
have different actions in mice and humans (fig. 7). Using GPR30
KO mice, it has recently been demonstrated that in addition to
ERb, GPR30 may also participate in the insulinotropic action of
E2 in mice [38]. Moreover, it is known that activation of GPR30
by its agonist G1 is insulinotropic in mouse and human islets
[22,52] and regulates glucagon and somatostatin release from a
and d cells within the islet of Langerhans. Other not yet identified
receptors acting on b- and other types of cells may also have a role
in BPA signalling [31,32,53,54].
The use of b-cells from genetically modified mice indicates that
BPA cannot longer be considered a weak estrogen because it is
equally potent to the natural hormone E2 when acting via
nonclassical ER-mediated pathways. The rapid insulinotropic
action of BPA described in mice also occurs in human islets and in
Figure 6. Insulinotropic action of BPA on isolated human islets
of Langerhans. Stimulatory glucose concentration elicited insulin
secretion that was enhanced almost 2 fold in presence of 1 nM BPA.
Activation of ERb by specific agonist DPN raised insulin secretion at
8 mM glucose concentration. *, P,0.05, **, P,0.01, ***, P,0.001
Student’s t-test.
doi:10.1371/journal.pone.0031109.g006
Figure 7. Model of BPA action on pancreatic b-cells. In the presence of stimulatory glucose concentrations, low concentrations of BPA rapidly
decrease KATP channel activity through ERb, enhancing glucose-induced [Ca
2+]i signals and insulin release. ERa is involved in the regulation of
pancreatic insulin biosynthesis in response to BPA. In addition to ERb, GPR30/GPER1 or another yet unidentified non-classical membrane estrogen
receptor may participate in the insulinotropic effect of BPA on pancreatic b-cells. At the moment, this model applies to rodent beta cells. In humans,
the receptors involved in the BPA regulation of KATP channel activity and insulin release are still undetermined.
doi:10.1371/journal.pone.0031109.g007
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a stronger manner to that in mice. This should have important
implications for the policy of exposure of humans to BPA. There is
an ongoing debate among environmental agencies worldwide
about whether BPA can be considered a hazard for human health.
One of the constant points of discussion is the relevance of
extrapolation of animal results to humans. The demonstration that
BPA at concentrations found in human serum alters human b-cell
function strongly indicates that at least some of the adverse effects
of BPA on glucose homeostasis described in mice may be
translated to humans.
Supporting Information
Figure S1 Activation of ERb by DPN decreased KATP
channel activity in human pancreatic b-cells. 1 nM DPN,
specific agonist of ERb, decreased KATP channel activity in
isolated human pancreatic b-cells (1 nM DPN trace) compared
with control conditions at 0 mM glucose concentration (vehicle
trace). (n = 2).
(TIF)
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